Immune Therapeutics: Appointment of Chief Financial Officer and Chief Operating Officer – Form 8-K
Immune Therapeutics Appoints Chief Monetary Officer and Chief Working Officer ORLANDO, Fla., August 4, 2022 (GLOBE NEWSWIRE) – Immune Therapeutics Inc. (OTC PINK:IMUN) (“Immune” or “IMUN”) is a specialty pharmaceutical firm concerned within the acquisition, improvement and commercialization of pharmaceutical and biotechnology merchandise with quick and well-defined paths to market. Appointed Glenn Farmer as Chief … Read more